Pitfalls in assessing platelet activation status in patients with liver disease

Liver International

Volumn 32, Issue 6, 2012, Pages 1027-

  Lisman, Ton ^a   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; PADGEM PROTEIN;

CORRELATION ANALYSIS; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LETTER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; FEMALE; HUMANS; ISOPROSTANES; LIVER CIRRHOSIS; MALE; NADPH OXIDASE; OXIDATIVE STRESS; PLATELET ACTIVATION;

EID: 84861963151     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02737.x     Document Type: Letter

References (4)

1. Basili S, Raparelli V, Riggio O, et al. CALC Group. NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation. Liver Int 2011; 31: 1533 40.
2. Ogasawara F, Fusegawa H, Haruki Y, et al. Platelet activation in patients with alcoholic liver disease. Tokai J Exp Clin Med 2005; 30: 41 8.
3. Fusegawa H, Shiraishi K, Ogasawara F, et al. Platelet activation in patients with chronic hepatitis C. Tokai J Exp Clin Med 2002; 27: 101 6.
4. Laffi G, Cinotti S, Filimberti E, et al. Defective aggregation in cirrhosis is independent of in vivo platelet activation. J Hepatol 1996; 24: 436 43.